XML 48 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows
$ in Thousands
 9 Months Ended
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Cash flows from operating activities    
Net income (loss) $ 47,592 $ (3,579)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 91,618 81,627
Provision for doubtful accounts and sales returns 1,721 4,815
Stock-based compensation expense 76,430 95,668
Deferred taxes (21,776) (31,163)
Amortization of deferred financing costs and discount 1,786 1,388
Loss on disposition of business 1,561 0
Other non-cash adjustments 2,462 5,106
Changes in operating assets and liabilities, net of acquisition and disposal of businesses:    
Accounts receivable 918 (4,757)
Prepaid expenses and other assets (873) 14,488
Trade accounts payable 18,322 (3,362)
Accrued expenses and other liabilities (16,373) 9,073
Deferred revenue 18,998 33,679
Net cash provided by operating activities 222,386 202,983
Cash flows from investing activities    
Purchase of property and equipment (7,235) (4,243)
Capitalized software and content development costs (42,882) (44,664)
Purchase of net assets of acquired companies, net of cash and restricted cash acquired 0 (13)
Net cash used in disposition of business (1,179) 0
Other investing activities (5,029) (250)
Net cash used in investing activities (56,325) (49,170)
Cash flows from financing activities    
Proceeds from issuance of debt 1,303,400 175,800
Payments on debt (1,080,192) (293,957)
Debt issuance costs (6,458) 0
Employee taxes paid for withheld shares upon equity award settlement (55,950) (35,568)
Change in due to customers (263,732) (339,735)
Change in customer funds receivable (6,777) (3,286)
Purchase of treasury stock (325,408) 0
Net cash used in financing activities (435,117) (496,746)
Effect of exchange rate on cash, cash equivalents and restricted cash 3,527 (311)
Net decrease in cash, cash equivalents and restricted cash (265,529) (343,244)
Cash, cash equivalents and restricted cash, beginning of period 728,257 733,931
Cash, cash equivalents and restricted cash, end of period 462,728 $ 390,687
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]    
Cash and cash equivalents 34,633  
Total restricted cash 428,095  
Total cash, cash equivalents and restricted cash in the statement of cash flows $ 462,728